VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
OPKOPKO Health, Inc.
$1.53$1.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksOPKQuarterly Financials

OPKO Health, Inc. (OPK) Quarterly Financials

120+ quarters historyFree accessUpdated daily

OPKO Health, Inc. (OPK) quarterly income statement — complete revenue, gross profit & net income history

OPK Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue124.2M148.5M151.67M156.81M149.95M183.64M173.63M182.19M173.69M181.9M178.59M265.42M
Revenue Growth %-17.18%-19.13%-12.65%-13.93%-13.66%0.96%-2.78%-31.36%-26.89%-1.86%-0.64%-14.35%
Cost of Goods Sold56.14M60M80.4M107.41M107.33M98.98M133.5M130.53M131.62M137.2M130.92M138.94M
COGS % of Revenue45.21%40.4%53.01%68.49%71.58%53.9%76.89%71.65%75.78%75.42%73.3%52.35%
Gross Profit68.05M88.5M71.27M49.4M42.62M84.66M40.13M51.65M42.07M44.71M47.68M126.48M
Gross Margin %54.79%59.6%46.99%31.5%28.42%46.1%23.11%28.35%24.22%24.58%26.7%47.65%
Gross Profit Growth %59.67%4.54%77.59%-4.36%1.31%89.36%-15.83%-59.16%-57.62%-20.16%52.33%9.43%
Operating Expenses119.07M126.8M23.21M109.38M109.79M117.8M25.91M113.32M113.54M113.75M112.08M119.49M
OpEx % of Revenue95.87%85.39%15.3%69.76%73.22%64.15%14.92%62.2%65.37%62.54%62.76%45.02%
Selling, General & Admin48.61M50.5M53.8M59.6M59.09M67.03M98.2M68.82M70.17M72.9M72.24M79.79M
SG&A % of Revenue39.14%34.01%35.47%38.01%39.4%36.5%56.56%37.78%40.4%40.08%40.45%30.06%
Research & Development29.2M32.8M30.08M30.34M30.84M30.43M28.77M24.08M21.94M19.4M19.43M18.16M
R&D % of Revenue23.51%22.09%19.83%19.35%20.57%16.57%16.57%13.22%12.63%10.67%10.88%6.84%
Other Operating Expenses1000K1000K-1000K1000K1000K1000K-1000K1000K1000K1000K1000K1000K
Operating Income-51.02M-38.3M48.06M-59.98M-67.17M-33.14M14.22M-61.67M-71.47M-69.05M-64.41M7.03M
Operating Margin %-41.08%-25.79%31.68%-38.25%-44.79%-18.05%8.19%-33.85%-41.15%-37.96%-36.06%2.65%
Operating Income Growth %24.05%-15.57%238.04%2.74%6.02%52%122.07%-977.86%-133.61%-24.93%26.66%165.42%
EBITDA-51.02M-15.93M70.8M-36.95M-43.68M-9.1M38.38M-37.52M-45.65M-43.06M-38.09M33.57M
EBITDA Margin %-41.08%-10.73%46.68%-23.57%-29.13%-4.96%22.1%-20.59%-26.28%-23.67%-21.32%12.65%
EBITDA Growth %-16.79%-75.02%84.47%1.5%4.32%78.87%200.77%-211.74%-1000.58%-49.48%38.01%94.55%
D&A (Non-Cash Add-back)022.37M22.74M23.03M23.49M24.04M24.16M24.16M25.82M25.98M26.32M26.55M
EBIT0-42.79M52.79M-92.19M-57.91M49.22M65.78M-2.4M-75.5M-69.04M-74.99M-13.17M
Net Interest Income0-2.45M-8.34M-67.04M-10.79M-9.95M-14.43M-7.79M-6.87M-2.55M-2.41M-2.2M
Interest Income3.01M1.66M3.02M3.29M4.68M4.29M2.93M391K813K906K970K1.08M
Interest Expense-10.94M4.11M11.36M70.33M15.47M14.24M17.36M8.18M7.69M3.45M3.38M3.28M
Other Income/Expense-9.94M-8.6M-6.63M-102.54M-6.21M68.12M34.2M51.09M-11.71M-3.45M-13.97M-23.52M
Pretax Income-60.96M-46.9M41.43M-162.52M-73.37M34.98M48.42M-10.58M-83.18M-72.5M-78.38M-16.49M
Pretax Margin %-49.08%-31.58%27.32%-103.64%-48.93%19.05%27.88%-5.81%-47.89%-39.86%-43.89%-6.21%
Income Tax-6.11M-15.7M19.8M-14.08M-5.76M20.95M23.53M-280K-1.35M-6.02M6.08M3.15M
Effective Tax Rate %10.02%33.48%47.78%8.66%7.85%59.87%48.59%2.65%1.62%8.3%-7.75%-19.09%
Net Income-54.85M-31.3M21.63M-148.44M-67.61M14.03M24.89M-10.3M-81.84M-66.48M-84.47M-19.64M
Net Margin %-44.16%-21.08%14.26%-94.66%-45.09%7.64%14.33%-5.66%-47.12%-36.55%-47.3%-7.4%
Net Income Growth %18.88%-323.14%-13.09%-1340.48%17.38%121.1%129.47%47.53%-348%22%1.88%80.68%
Net Income (Continuing)-54.85M-31.2M21.63M-148.44M-67.61M14.03M24.89M-10.3M-81.84M-66.48M-84.47M-19.64M
Discontinued Operations000000000000
Minority Interest000000000000
EPS (Diluted)-0.07-0.040.03-0.22-0.100.020.03-0.01-0.12-0.09-0.11-0.03
EPS Growth %30%-301.98%-7.67%-1386.49%16.67%122.82%127.27%43.3%-395.87%19.55%0%81.36%
EPS (Basic)-0.07-0.040.03-0.22-0.100.020.04-0.01-0.12-0.09-0.11-0.03
Diluted Shares Outstanding758.88M765.52M779.92M671.58M671.58M694.02M695.62M697.21M706.88M751.51M751.52M751.73M
Basic Shares Outstanding758.88M765.52M777.15M671.58M671.58M797.44M694.62M697.21M706.88M751.51M751.52M751.73M
Dividend Payout Ratio------------